Article info
PDFSystemic sclerosis
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
- Correspondence to Dr Oliver Distler, Department of Rheumatology, University of Zurich, University Hospital Zurich, 8091 Zurich, Switzerland; oliver.distler{at}usz.ch
Citation
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
Publication history
- Received May 5, 2021
- Accepted November 9, 2021
- First published November 25, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (10 March 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.